Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China

QR Code

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China

Ling Zhang,1–4 Yun Chen,5 Li Yue,5 Qingjing Liu,6 William Montgomery,7 Lihua Zhi,5 Wanqi Wang51Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, 2China Clinical Research Center for Mental Disorders, 3China Center of Depression, Beijing Institute for Brain Disorder...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zhang L, Chen Y, Yue L, Liu Q, Montgomery W, Zhi L, Wang W
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	depression China antidepressants healthcare resource persistence Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/f0ceeeb1c6954c8090e823c90bbd6552
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
par: Novick D, et autres
Publié: (2016)

Prevalence and correlates of cognitive impairment and depression among elderly people in the world’s fastest growing city, Chongqing, People’s Republic of China
par: Giri M, et autres
Publié: (2016)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
par: Bhattacharjee S, et autres
Publié: (2020)

El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
par: LEYTON A,FANNY, et autres
Publié: (2010)

Psicofarmacoterapia antidepresiva
par: Retamal C,Pedro
Publié: (2001)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
par: Durgam S, et autres
Publié: (2016)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
par: L. K. Khokhlov, et autres
Publié: (2019)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
par: Blat Diana, et autres
Publié: (2021)

Different molecular targets, one purpose – treatment of depression
par: Burat Magdalena, et autres
Publié: (2020)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
par: Harada E, et autres
Publié: (2016)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
par: Jha MK, et autres
Publié: (2017)

¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
par: Silva,Hernán, et autres
Publié: (2007)

Farmacoterapia de los trastornos depresivos unipolares en la mujer
par: Rees,Reginald
Publié: (2002)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
par: Weiller E, et autres
Publié: (2017)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
par: Thase ME, et autres
Publié: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
par: Michael Colla, et autres
Publié: (2021)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
par: Otsubo T, et autres
Publié: (2018)

Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016)

Depresión Mayor y Salud Oral: Rol de los Fármacos Antidepresivos
par: Rojas,Gonzalo, et autres
Publié: (2000)

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review
par: Woranush W, et autres
Publié: (2021)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
par: Solem CT, et autres
Publié: (2016)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
par: Park YM, et autres
Publié: (2016)

The burden of caring for adults with depression and suicidal ideation in five large European countries: analysis from the 2020 National Health and Wellness Survey
par: D. H. Jaffe, et autres
Publié: (2021)

Cognitive impairment in depression: recent advances and novel treatments
par: Perini G, et autres
Publié: (2019)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
par: Baune BT, et autres
Publié: (2021)

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study
par: Hsing SC, et autres
Publié: (2020)

Relationship between suicide rate and economic growth and stock market in the People’s Republic of China: 2004–2013
par: Yin HL, et autres
Publié: (2016)

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
par: Zeng D, et autres
Publié: (2018)

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
par: Wu J, et autres
Publié: (2015)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
par: Sugawara N, et autres
Publié: (2020)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
par: Sergey N. Mosolov
Publié: (2020)

Immunoregulation and antidepressant effect of ketamine
par: Zhang Nan, et autres
Publié: (2021)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
par: O. V. Petrunko
Publié: (2014)

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
par: Lunghi C, et autres
Publié: (2020)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
par: Tomita T, et autres
Publié: (2016)

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
par: Nuria Carballo, et autres
Publié: (2021)

Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China
par: Chen Y, et autres
Publié: (2016)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
par: Takeshima M, et autres
Publié: (2020)

Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
par: Soraia Silva, et autres
Publié: (2021)